Zhejiang Runtu (002440.SZ) forecasts a year-on-year increase in net profit of 293.26% - 402.50% for the year 2024.
Runterra Corporation (002440.SZ) released its performance forecast for 2024, expecting full-year net profit attributable to shareholders of the listed company to...
Zhejiang Runtu (002440.SZ) has released its performance forecast for the year 2024, with an expected net profit attributable to shareholders of the listed company of 180 million to 230 million yuan, a year-on-year growth of 293.26% to 402.50%.
Related Articles
Zelgen Biopharmaceutical (688266.SH): New Drug Application for Gecacitinib Hydrochloride Tablets for the Treatment of Active Ankylosing Spondylitis Accepted
Services and wealth management businesses become key "engine"! Citigroup (C.US) Q3 net profit surges 40% year-over-year, EPS beats expectations.
A-share Announcement Highlights | Tungsten industry leader's net profit expected to rise over 200%; CATL plans to contribute 400 million yuan to participate in a venture capital fund.
Zelgen Biopharmaceutical (688266.SH): New Drug Application for Gecacitinib Hydrochloride Tablets for the Treatment of Active Ankylosing Spondylitis Accepted
Services and wealth management businesses become key "engine"! Citigroup (C.US) Q3 net profit surges 40% year-over-year, EPS beats expectations.
A-share Announcement Highlights | Tungsten industry leader's net profit expected to rise over 200%; CATL plans to contribute 400 million yuan to participate in a venture capital fund.
